Insmed Inc. buy Wells Fargo & Company
Start price
19.02.25
/
50%
€78.00
Target price
19.02.26
€102.54
Performance (%)
74.36%
End price
20.02.26
€136.00
Summary
This prediction ended on 20.02.26 with a price of €136.00. With a performance of 74.36% the BUY prediction by Wells_Fargo___Compan was a big success. Wells_Fargo___Compan has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -7.143% | -7.143% | 134.234% |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Wells Fargo & Company from $85.00 to $107.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten